Alpha Cognition Inc. Operating Cash Flow
Alpha Cognition Inc. (ACOG) reported Operating Cash Flow of -$18.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- Alpha Cognition Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.86M.
- Alpha Cognition Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$11.80M.
- Alpha Cognition Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.91M.
- Alpha Cognition Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.29M.
- Alpha Cognition Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$20.38M.
- Alpha Cognition Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$7.76M.
- Alpha Cognition Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$8.80M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$18.66M 10-Q · filed 2026-08-13 | -$25.56M derived: sum of 3 quarters · filed 2026-08-13 | -$30.85M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$11.80M 10-Q · filed 2026-05-14 | -$18.70M derived: sum of 2 quarters · filed 2026-05-14 | -$23.99M derived: sum of 3 quarters · filed 2026-05-14 | -$30.13M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$6.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$12.20M derived: sum of 2 quarters · filed 2026-03-31 | -$18.34M derived: sum of 3 quarters · filed 2026-08-13 | -$20.38M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$5.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$11.43M derived: sum of 2 quarters · filed 2026-08-13 | -$13.47M 10-Q · filed 2025-11-13 | -$15.78M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$6.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$8.18M 10-Q · filed 2026-08-13 | -$10.49M derived: sum of 3 quarters · filed 2026-08-13 | -$12.07M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$2.04M 10-Q · filed 2026-05-14 | -$4.35M derived: sum of 2 quarters · filed 2026-05-14 | -$5.93M derived: sum of 3 quarters · filed 2026-05-14 | -$7.33M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.88M derived: sum of 2 quarters · filed 2026-03-31 | -$5.28M derived: sum of 3 quarters · filed 2026-03-31 | -$7.76M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.98M derived: sum of 2 quarters · filed 2025-11-13 | -$5.45M 10-Q · filed 2025-11-13 | -$7.48M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$3.87M 10-Q · filed 2025-08-14 | -$5.90M derived: sum of 3 quarters · filed 2025-08-14 | -$7.51M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$2.47M 10-Q · filed 2025-05-15 | -$4.50M derived: sum of 2 quarters · filed 2025-05-15 | -$6.11M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.63M derived: sum of 2 quarters · filed 2025-03-31 | -$8.80M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$6.77M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$5.17M 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |